SCO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.175000E-01
Normal-vs-Stage2
4.743000E-01
Normal-vs-Stage3
1.955970E-01
Normal-vs-Stage4
7.263000E-01
Stage1-vs-Stage2
2.408800E-01
Stage1-vs-Stage3
1.493590E-01
Stage1-vs-Stage4
6.649800E-01
Stage2-vs-Stage3
2.905800E-01
Stage2-vs-Stage4
6.579000E-01
Stage3-vs-Stage4
2.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.625200E-01
Normal-vs-AfricanAmerican
8.561800E-01
Normal-vs-Asian
4.124600E-01
Caucasian-vs-AfricanAmerican
5.263000E-01
Caucasian-vs-Asian
7.187400E-01
AfricanAmerican-vs-Asian
3.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.442000E-01
Normal-vs-Female
7.714000E-01
Male-vs-Female
1.004010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.156600E-01
Normal-vs-Age(41-60Yrs)
9.863000E-01
Normal-vs-Age(61-80Yrs)
2.901400E-01
Normal-vs-Age(81-100Yrs)
7.557200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.266800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.638600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.490200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.737800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.057000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.100600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.370800E-01
Normal-vs-Daily Drinker
1.824580E-01
Normal-vs-Weekly Drinker
7.794400E-01
Normal-vs-Occasional Drinker
8.333800E-01
Normal-vs-Social Drinker
8.666600E-01
Non Drinker-vs-Daily Drinker
8.240800E-01
Non Drinker-vs-Weekly Drinker
5.085000E-01
Non Drinker-vs-Occasional Drinker
1.512390E-01
Non Drinker-vs-Social Drinker
1.992820E-01
Daily Drinker-vs-Weekly Drinker
4.272400E-01
Daily Drinker-vs-Occasional Drinker
8.648100E-02
Daily Drinker-vs-Social Drinker
1.744750E-01
Weekly Drinker-vs-Occasional Drinker
7.733400E-01
Weekly Drinker-vs-Social Drinker
7.907200E-01
Occasional Drinker-vs-Social Drinker
9.877800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.303000E-01
Normal-vs-Grade 2
7.927600E-01
Normal-vs-Grade 3
8.094200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.250800E-01
Grade 1-vs-Grade 3
6.147400E-01
Grade 1-vs-Grade 4
8.303000E-01
Grade 2-vs-Grade 3
5.229200E-01
Grade 2-vs-Grade 4
7.927600E-01
Grade 3-vs-Grade 4
8.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.348800E-01
Normal-vs-NonDiabetic
5.307600E-01
Diabetic-vs-NonDiabetic
4.079800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.216400E-01
Normal-vs-NoPancreatitis
5.137800E-01
Pancreatitis-vs-NoPancreatitis
8.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.055400E-01
Normal-vs-N1
4.471800E-01
N0-vs-N1
1.191030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.080600E-01
Normal-vs-TP53-NonMutant
7.541000E-01
TP53-Mutant-vs-TP53-NonMutant
4.675900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
